Dr. Julie Brahmer on the PD-1 Targeted Immunotherapy BMS-93655 Clinical Trial OncLive 1:21 12 years ago 1 529 Далее Скачать
Dr. Suzanne Topalian on the PD-1 Targeted Therapy BMS-936558 OncLive 1:27 12 years ago 2 764 Далее Скачать
Dr. Julie R. Brahmer on Immunotherapy Development in Lung Cancer OncLive 0:58 9 years ago 505 Далее Скачать
Copy of Dr. Brahmer on the Role of Immunotherapy in Metastatic NSCLC OncLive 0:31 6 years ago 21 Далее Скачать
Dr. Scott Gettinger on the PD-1 Inhibitor BMS-936558 in Non-Small Cell Lung Cancer OncLive 1:23 12 years ago 1 293 Далее Скачать
Dr. Suzanne Topalian on the Targeted PD-1 Immunotherapy BMS-936558 OncLive 0:53 12 years ago 386 Далее Скачать
Immunotherapy for Lung Cancer: What Patients Need to Know, with Julie Brahmer Cancer Research Institute 1:00:52 9 years ago 24 105 Далее Скачать
Dr. Brahmer Discusses the Outlook for Immunotherapies Targeted Oncology 0:58 11 years ago 93 Далее Скачать
Julie Brahmer, MD, talks about the potential impact of immunotherapy in 1st line NSCLC OBRoncology 0:41 8 years ago 32 Далее Скачать
Cancer Immunotherapy in Lung Cancer Discussed by Dr. Julie Brahmer Society for Immunotherapy of Cancer 2:05 11 years ago 551 Далее Скачать
Immunotherapy for Metastatic Melanoma — PD-1 Clinical Trials MelanomaReAlli 1:50 10 years ago 1 605 Далее Скачать
Dr. Brahmer on the Role of Immunotherapy in Metastatic NSCLC OncLive 1:31 6 years ago 64 Далее Скачать
Dr. Brahmer Discusses Frontline Single-Agent Pembrolizumab in Lung Cancer OncLive 1:48 6 years ago 629 Далее Скачать
Dr. Brahmer on the Benefit of Immunotherapy in Metastatic NSCLC OncLive 1:32 6 years ago 95 Далее Скачать
